Similarly, IRF6 (Interferon regulatory factor 6), a key regulator of epithelial adhesion and has non-TF roles in the recycling of E-cadherin, is also a favourable prognostic marker in BC, with high levels enhancing treatment sensitivity and inhibiting tumorigenesis42. This evidence concerns the gene CDH1 and breast cancer.